About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Beyond Biotech podcast 23: World Antimicrobial Awareness Week, PsychoGenics

New EU project looks to unlock the potential of genomics

Astellas meets primary endpoint in gastric cancer study

VISEN growth hormone deficiency trial results announced

FundaMental Pharma launches with €10M to advance first-in-class neuroprotectant

New mitochondria study could pave way for disease treatments

ADVERTISEMENT

Enzymes could be key to understanding ‘origin of DNA errors’

Growth in UK cell and gene therapy sector continues

Kadans Science Partner to develop new London life sciences innovation facility

Immutep announces efti clinical results for non-small cell lung cancer

Poolbeg-led consortium awarded €2.3m to develop oral vaccine platform

Jnana Therapeutics raises $107M for PKU program and announces new Roche partnership

ADVERTISEMENT